Categories
Health

CDC says totally vaccinated academics and college students needn’t put on masks indoors in up to date steering

Students wearing masks listen to teacher Dorene Scala during third grade summer school at Hooper Avenue School on June 23, 2021, in Los Angeles.

Carolyn Cole | Los Angeles Times | Getty Images

The Centers for Disease Control and Prevention updated its public health guidance for schools Friday, saying fully vaccinated teachers and students don’t need to wear masks inside school buildings.

The CDC’s new guidance comes about two months after federal health officials permitted the use of the Pfizer-BioNTech Covid vaccine for kids ages 12 to 15, allowing middle and high school students to get the shots ahead of the fall school semester.

Teachers and students who are not vaccinated should still continue to wear masks indoors, the U.S. agency said, adding the practice is especially important when inside and in crowded settings, when social distancing cannot be maintained.

The agency also said it still recommends that students remain at least 3 feet apart in classrooms, combined with indoor mask wearing by people who are not fully vaccinated, to reduce the risk of transmission of the virus.

“When it is not possible to maintain a physical distance of at least 3 feet, such as when schools cannot fully re-open while maintaining these distances, it is especially important to layer multiple other prevention strategies, such as indoor masking,” the CDC wrote in its guidance.

The CDC’s recommendation will likely have no impact on students under 12, who are currently ineligible to get a Covid vaccine in the U.S.

The updated guidance comes as several states across the U.S. have largely done away with their mask requirements, social distancing and other pandemic-related restrictions because the Covid vaccines have helped drive down the number of new infections and deaths.

In mid-May, the CDC said fully vaccinated people didn’t need to wear masks in most settings, whether indoors or outdoors. They are still expected to wear masks on public transportation, the agency said, such as on airplanes, buses and trains. The federal government’s mask mandate on public transportation is scheduled to expire on Sept. 13 unless the CDC extends it once again.

The guidance may be controversial as scientists and other health experts say indoor mask mandates many make a return this fall, particularly in low vaccinated states, as the highly transmissible delta variant spreads across the U.S.

Already the dominant variant in the U.S., delta will hit the states with the lowest vaccination rates the hardest — unless those states and businesses reintroduce mask rules, capacity limits and other public health measures that they’ve largely rolled back in recent months, experts say.

This is a developing story. Please check back for updates.

Categories
Health

C.D.C. Requires Up to date Childhood Vaccinations After Decline Final 12 months

Pediatricians urge U.S. parents to get their children given routine vaccinations after vaccinations for diseases such as measles declined last year as the pandemic imposed restrictions, including the arrangement of homes.

New data from 10 jurisdictions that closely monitor vaccinations confirms that the number of vaccine doses administered fell between March and May last year, particularly in older children, the Centers for Disease Control and Prevention reported Thursday.

Although vaccinations recovered between June 2020 and September 2020 and were approaching pre-pandemic levels, the increase was insufficient to offset the earlier decline, the study found.

Vaccination is required to attend most schools, camps and daycare, but the CDC study authors warned that the delay could nonetheless pose “a serious public health threat that would lead to vaccine-preventable disease outbreaks.”

They expressed concern that the move to distance learning during the pandemic may have hampered enforcement of vaccination regulations, noting that even a temporary drop in vaccination can affect herd immunity.

A measles outbreak occurred in Rockland County, NY and surrounding counties in 2018-2019 after the measles vaccination rate in schools in the area dropped to 77 percent, among the 93 to 95 percent required to maintain herd immunity are. “Pediatric outbreaks of vaccine-preventable diseases can undo efforts to reopen schools this fall,” the researchers added.

Parents should plan ahead now and make appointments so their children can be protected, said Dr. Yvonne Maldonado, Chair of the Infectious Diseases Committee at the American Academy of Pediatrics.

“We should start thinking about it,” said Dr. Maldonado in a telephone interview. “People forget. We have whooping cough outbreaks regularly every four or five years and are just waiting to see another. “

“We’ll likely see more infections because the kids will get back together and there will be less masking and social distancing,” she added.

The CDC analyzed data from nine states and New York City. In eight of the jurisdictions, a stay at home order was issued last spring.

The number of doses of diphtheria, tetanus and pertussis vaccines (DTaP) administered decreased by 15.7 percent in children under 2 years of age and in children aged from in the spring of last year compared to the same period in 2018 and 2019 2 to 6 years back by 60 percent.

The vaccine doses against measles, mumps and rubella (MMR) fell by 22.4 percent in 1-year-olds and by 63 percent in 2 to 8-year-olds.

HPV vaccine administration decreased more than 63 percent in adolescents aged 9-17 years compared to the same period in 2018 and 2019; and doses of Tdap (tetanus, diphtheria, and whooping cough) decreased by over 60 percent.

Categories
Health

The CDC ought to have up to date its surface-cleaning tips a lot sooner, Dr. Ashish Jha says

Centers for Disease Control and Prevention should have their home surface cleaning guidelines updated in good time before this week, the dean of Brown University’s School of Public Health said Tuesday.

“It’s incredibly frustrating,” said Dr. Ashish Jha on CNBC’s “The News with Shepard Smith”. “I think I started saying in April and May that a lot of us in public health are quitting wiping surfaces.”

“I really don’t understand why it took CDC so long to get really clear. This virus is spreading through the air,” Jha said.

The CDC said Monday that a thorough soap-and-water scrub is enough to prevent the spread of Covid-19 around the home. However, the use of disinfectants is recommended in schools and private homes where a suspected or confirmed virus case has appeared within 24 hours.

“In most situations, regular cleaning of the surfaces with soap and detergent is enough to not necessarily disinfect these surfaces to reduce the risk of the spread of COVID-19,” said CDC Director Dr. Rochelle Walensky in a meeting at the White House on Monday.

Jha noted that the CDC’s public health news was part of a larger pattern of bad government news when it comes to Covid.

“I would say the first few months were confusing, but by April and May of last year it was clear that this was in the air,” Jha said. “It was frustrating that our federal officials didn’t always get this out consistently.”

The CDC did not immediately respond to CNBC’s request for comment.

Host Shepard Smith also asked Jha about the highly contagious variant B.1.1.7 after Michael Osterholm, director of the Center for Research and Policy on Infectious Diseases, warned on Sunday that the variant could infect children more easily than previous strains.

Jha said he was “concerned” about the B.1.1.7 variant in children, particularly because they have not yet been vaccinated.

“We don’t see a lot of infections in older people because we get them vaccinated and that makes young adults and children really susceptible to B.1.1.7,” noted Jha. “One of the reasons we can’t fully relax right now is because we really need to cut those numbers of infections.”

Every state in the country has reported at least one case of variant B.1.1.7, which was first discovered in the UK, CDC data shows. Walensky said Wednesday that the variant is becoming the predominant strain of Covid in many regions of the United States

Categories
World News

AstraZeneca points up to date part three trial knowledge

A healthcare worker prepares to inject a vaccine against AstraZeneca coronavirus disease (COVID-19).

Eloisa Lopez

AstraZeneca released updated Phase 3 trial data for its Covid-19 vaccine on Wednesday after asking accuracy questions related to a preliminary report from its US study earlier this week.

The company now says its vaccine is 76% effective against symptomatic virus cases. A press release published on Monday reported a symptomatic efficacy rate of 79%. The updated report claims the shot is 100% effective against serious illness and hospital stays.

A group of US health officials criticized the company over the past few days for claiming that they are collecting data to make the results seem more favorable.

The National Institute of Allergy and Infectious Diseases announced Tuesday that the UK-based company may have included information from its US findings that provided an “incomplete view of efficacy data”.

AstraZeneca said at the time that the numbers were based on a “pre-determined interim analysis” and promised to share the updated analysis in the coming days.

Dr. Anthony Fauci, Chief Medical Officer and White House Director at NIAID, described the situation as “unfortunate” and said it was likely that AstraZeneca would issue a modified statement.

“This is really what you call an easy mistake as it is most likely a very good vaccine,” Fauci told ABC’s Robin Roberts on Good Morning America Tuesday. “Something like that … really creates doubts about the vaccines and maybe adds to hesitation. It wasn’t necessary.”

The updated results include data from 190 symptomatic cases in more than 32,000 participants – an increase of around 50 symptomatic cases studied compared to the dataset published Monday.

The results suggest that the vaccine is more effective than previously thought in patients aged 65 and over, with a newly reported efficacy rate of 85% for this population versus 80% previously reported.

AstraZeneca reiterated Wednesday that the vaccine was “well tolerated” among participants and that no safety concerns were identified.

AstraZeneca has faced a separate backlash over the past few weeks due to reports of blood clotting related to its vaccine, which is already approved and used by dozen of countries around the world. Several European nations have suspended and then resumed use of the vaccine after independent safety reviews.

– CNBC’s Berkeley Lovelace Jr., Sam Meredith, and Steve Kopack contributed to this report.